key: cord-0940523-9mm83v8k
authors: Zhang, Tongqiang; Cui, Xiaojian; Zhao, Xue; Wang, Jinhu; Zheng, Jiafeng; Zheng, Guifen; Guo, Wei; Cai, Chunquan; He, Sijia; Xu, Yongsheng
title: Detectable SARS‐CoV‐2 viral RNA in feces of three children during recovery period of COVID‐19 pneumonia
date: 2020-04-15
journal: J Med Virol
DOI: 10.1002/jmv.25795
sha: 8d17081037d324fd373571237ae27c4aef33f2ed
doc_id: 940523
cord_uid: 9mm83v8k

Coronavirus Disease 2019 (COVID‐19) is a newly emerging infectious disease caused by a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). After its first occurrence in Wuhan of China from December 2019, COVID‐19 rapidly spread around the world. According to the World Health Organization statement on 13 March 2020, there had been over 132 500 confirmed cases globally. Nevertheless, the case reports of children are rare, which results in the lack of evidence for preventing and controlling of children's infection. Here, we report three cases of SARS‐CoV‐2 infected children diagnosed from 3 February to 17 February 2020 in Tianjin, China. All of these three cases experienced mild illness and recovered soon after the treatment, with the nucleic acid of throat swab turning negative within 14, 11, and 7 days after diagnosis, respectively. However, after been discharged, all three cases were tested SARS‐CoV‐2 positive in the stool samples within 10 days, in spite of their remained negative nucleic acid in throat swab specimens. Therefore, it is necessary to be aware of the possibility of fecal‐oral transmission of SARS‐CoV‐2 infection, especially for children cases.

Coronavirus Disease 2019 (COVID-19) caused by a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has rapidly spread worldwide since its onset in Wuhan throughout December 2019. [1] [2] [3] There was a total of 132 536 confirmed cases in 123 countries, areas or territories worldwide, and 4974 deaths till 13 March 2020. 4 The droplet spread or direct contact with fomites is considered to be the major routes of SARS-CoV-2 transmission, 3 while the fecal shedding is also considered to be a minor driver of transmission as a viable virus has been identified in a limited number of case reports. 5, 6 Most patients infected with SARS-CoV-2 were mild types and could be Tongqiang Zhang and Xiaojian Cui contributed equally to this work. cured. About 80% of laboratory-confirmed cases were mild and moderate cases in adults, including those with or without pneumonia, 13.8% of patients were severe illness, and 6.1% of patients were a critical illness. 7 Children infected with SARS-CoV-2 were mostly mild cases and few severe cases have been reported. 8 Given that children are in a special immune state, we need to be alert to the occurrence of severe cases. In this study, we collected three children cases diagnosed with COVID-19 from 3 February to 17 February 2020 in Tianjin. The clinical characteristics of these children were analyzed and reported to provide a reference for the diagnosis and treatment of children during the epidemic of COVID-19.

Children diagnosed with COVID-19 in Tianjin, China were recruited.

The diagnostic criteria for COVID-19 refer to the "New Coronavirus Infected Pneumonia Diagnosis and Treatment Program (Fifth Edition)" 9 issued by the National Health and Health Commission.

Basic information of children who were diagnosed with COVID-19: clinical characteristics, laboratory tests, chest imaging, etiological examination, treatment and outcome, and so forth were collected. The throat swab and fecal specimens were sent to Centers for Disease Control in Tianjin, China. The real-time reverse transcriptase-polymerase chain reaction (RT-PCR) nucleic acid tests were used to detect SARS-CoV-2 RNA.

This study followed the ethical requirements of biomedical research issued internationally and nationally strictly. All the following criteria 9 had to be met for hospital discharge or discontinuation of quarantine: (a) normal temperature lasting longer than 3 days, (b) resolved respiratory symptoms, (c) substantially improved acute exudative lesions on chest computed tomography (CT) images, and (d) two consecutively negative RT-PCR test results separated by at least 1 day.

All the three cases exhibited familial aggregation and experienced a history of close contact with their adult relatives who were diagnosed with COVID-19. All of them were male, aged 9, 6, and 8 years, respectively. Throat swab samples were collected on 1 to 14 days after onset of disease and the results of SARS-CoV-2 nucleic acid tests were positive. All the patients were classified as common type. Cases 1 and 3 had fever, nasal obstruction, runny nose, and digestive tract symptoms. Case 2 had mild clinical manifestations included cough, expectoration, and wheezing. As Case 1 combined with supportive tonsillitis, ceftriaxone anti-infection was used. Case 2 was given ribavirin antivirus treatment. All three cases were given interferon atomization, vitamin C, and oral Chinese medicine treatment. After the treatment, three patients obtained the negative throat swab nucleic acid in 14, 11, and 7 days, and were discharged from hospital with two times of negative results in 16, 13, and 9 days, respectively. Follow-up of isolation point after discharge: no positive result was found in either of the two times of throat swab nucleic acid tests, but the stool SARS-CoV-2 nucleic acid tests were positive after 10 days. The three patients were readmitted to the designated hospital. Neither clinical symptoms nor pathological changes in lung imaging were found in any cases. During the monitoring process, three cases appeared SARS-CoV-2 negative of stool specimens in 4, 5, and 10 days, respectively (Table 1 ).

Among the three children, Case 1 was complicated with purulent tonsillitis, with the increase of leukocyte and C-reactive protein (CRP) with 64.7 mg/L, and these indexes reduced to normal level after anti-infective treatment. Case 2 and Case 3 showed a normal range of white blood cells (WBC), CRP, and lymphocyte count. The hemoglobin and platelets were normal in three children. There was no obvious abnormality of troponin, blood gas analysis, electrolyte, liver and kidney function, or myocardial enzyme in three children with COVID-19. Serum procalcitonin, blood lactate dehydrogenase, and interleukin-6 were normal in three patients. The D-dimer was normal in all three children, but fibrinogen in Cases 2 and 3 was lower than normal. No bacterial growth was observed in the blood culture of three children, and Mycoplasma pneumoniae, chlamydia, respiratory syncytial virus, and adenovirus were negative.

Immunological examination (IgG, IgM, IgA, C3, and C4) were all in the normal range, and lymphocyte subsets (T cells, B cells, and NK cells) were basically normal. Urine and stool are normal. No abnormality was found either in electrocardiogram and echocardiography, or in liver, gallbladder, and kidney ultrasound ( Table 2 ).

In this study, three cases of children with lung CT were found positive, and two of them mainly showed ground-glass opacity (GGO), and one of them showed new cord shadow, which was located in the lower lung, outer band, near the pleura, and the scope was Figure 1E ). Ring slightly high-density shadow can be seen in the lesions of the right lower lobe.

Lung CT was rechecked 5 days after admission: the GGO of the two lungs was slightly absorbed and faded ( Figure 1F) . Length of hospital stay, d 16 13 9 Time from discharge to stool SARS-CoV-2 nucleic acid positive, d this study were classified as a common type of COVID-19, with no severe symptom. After infection, children's first symptoms were not typical, as most of them only got fever and cough, 6, 8 and some suffer from gastrointestinal symptoms. 15 Except for Case 1 with supportive tonsillitis, and obvious fever symptoms, no other serious symptoms were found in all of the three cases. Cases 1 and 3 had mild digestive tract symptoms, while Case 2 and Case 3 showed normal range of CRP, WBC, and lymphocyte count, which consistent with other studies. 8, 17 The lung CT showed ground-glass density shadow in two cases, which was typical manifestation of COVID-19 pneumonia. [18] [19] [20] As no specific antiviral drug available for SARS-CoV-2 infection to date, three patients were all treated with interferon nebulization, vitamin C, and Chinese medicine orally and had good results.

In 

Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series

A novel coronavirus from patients with pneumonia in China

Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia

World Health Organization. Coronavirus disease (COVID-19) outbreak

A case series of children with 2019 novel coronavirus infection: clinical and epidemiological features

Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding

Inspection Report C-WNCPC-J. China-WHO new coronavirus pneumonia (COVID-19) joint inspection report

Clinical analysis of 31 cases of 2019 novel coronavirus infection in children from six provinces (autonomous region) of northern China

General Office of the National Health and Health Commission. Diagnosis and treatment plan forpneumonia caused by new coronavirus

A novel coronavirus outbreak of global health concern

A novel coronavirus emerging in China -key questions for impact assessment

Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020

First case of severe childhood novel coronavirus pneumonia in China

SARS-CoV-2 infection in children: transmission dynamics and clinical characteristics

A case of neonatal SARS-CoV-2 infection with gastrointestinal symptoms as the first manifestation

China's first neonatal coronaviruspneumonia

Clinical and epidemiological characteristicsof 34 children with new coronavirus infection in ShenZhen

Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus

Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV): a study of 63 patients in Wuhan, China. Eur Radiol. 2020

Chest computed tomography in children with COVID-19 respiratory infection

First case of 2019 novel coronavirus in the United States

Detectable SARS-CoV-2 viral RNA in feces of three children during recovery period of COVID-19 pneumonia

The authors declare that there are no conflict of interests.

All authors contributed to the intellectual content of this manuscript and approved the final manuscript as submitted. TZ, XC, and XZ drafted the initial manuscript. JW, JZ, WG, CC, and GZ cared the patient and collected the clinical samples or data. SH and YX revised the article critically for important intellectual content.

The data used in this report are available from the corresponding author on reasonable request.

http://orcid.org/0000-0002-6945-1868Sijia He http://orcid.org/0000-0002-1932-1141